Roflumilast foam led to high response rates in seborrheic dermatitis Presented ByProf. Andrew Blauvelt, Oregon Medical Research Center, OR, USA TrialPhase 3, STRATUM ConferenceEADV 2022 TypePeer-reviewed article 5 November 2022 09:00